A Disintegrin And Metalloprotease 10 (ADAM10) Antibody (FITC)

Este producto es parte de ADAM10 - ADAM metallopeptidase domain 10
Product Graph
494€ (100 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
A Disintegrin And Metalloprotease 10 (ADAM10) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx270391
tested applications
FCM

Description

A Disintegrin And Metalloprotease 10 (ADAM10) Antibody (FITC) is a Rabbit Polyclonal Antibody conjugated to FITC against A Disintegrin And Metalloprotease 10 (ADAM10) for use in flow cytometry.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
A Disintegrin And Metalloprotease 10 (ADAM10)
Host
Rabbit
Reactivity
Human
Recommended Dilution
FCM: 1-5 µl/106 cells. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purification
Purified by antigen-specific affinity chromatography.
Size 1
100 tests
Size 2
200 tests
Size 3
500 tests
Form
Liquid
Tested Applications
FCM
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Please enquire.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
MADM, HsT18717,Kuz ,CD156d,AD10,AD18,RAK,KUZ,ADAM-10
Background
Antibody anti-ADAM10
Status
RUO

Descripción

ADAM10, also known as ADAM metallopeptidase domain 10, is a type I transmembrane glycoprotein belonging to the ADAM (a disintegrin and metalloproteinase) family of proteins. It is encoded by the ADAM10 gene located on human chromosome 15. ADAM10 plays crucial roles in various biological processes, including cell adhesion, cell fusion, cell signaling, proteolysis, and ectodomain shedding of membrane proteins. It is involved in the cleavage of a wide range of cell surface proteins, including cytokines, growth factors, adhesion molecules, and receptors. ( Notch receptors, amyloid precursor protein (APP), cadherins, and several cytokines and growth factors). The proteolytic activity of ADAM10 is tightly regulated, as its dysregulation can have significant implications in various diseases, including cancer, Alzheimer's disease, inflammation, and cardiovascular diseases. ADAM10-mediated cleavage of Notch receptors is crucial for various developmental processes, and dysregulation of this process has been implicated in cancer and neurodegenerative diseases. ADAM10 has gained significant attention as a potential therapeutic target for various diseases due to its involvement in critical cellular processes and its ability to modulate the activity of numerous substrates. Inhibition or modulation of ADAM10 activity is being explored as a strategy for the treatment of diseases such as cancer, Alzheimer's disease, and inflammatory disorders

Related Products

EH1041

Human ADAM10(Disintegrin and metalloproteinase domain-containing protein 10) ELISA Kit

Ver Producto
EM1631

Mouse ADAM10(Disintegrin and metalloproteinase domain-containing protein 10) ELISA Kit

Ver Producto
P8319

Recombinant Human ADAM10

Ver Producto